Page last updated: 2024-11-04

sotalol and Arteriosclerosis

sotalol has been researched along with Arteriosclerosis in 1 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Northcote, RJ1
Packard, CJ1
Ballantyne, D1

Other Studies

1 other study available for sotalol and Arteriosclerosis

ArticleYear
The effect of sotalol on plasma lipoproteins and apolipoproteins.
    Clinica chimica acta; international journal of clinical chemistry, 1986, Jul-30, Volume: 158, Issue:2

    Topics: Adult; Apolipoproteins; Arteriosclerosis; Cholesterol; Female; Humans; Hypertension; Lipoproteins; M

1986